1973•Australian & New Zealand Journal of PsychiatryRequires access

A Comparative Trial of Haloperidol and Thioridazine: Management of Chronic Schizophrenia

M. J. Weston, R. Bentley, A. Unwin, Margaret J. Morris, M. A. Harper

Abstract

A double-blind trial was conducted which attempted to compare and contrast the therapeutic effects of haloperidol and thioridazine in a chronic schizophrenic population. The psychiatric use of these two drugs, one a butyrophenone, the other a phenothiazine, is discussed with reference to the management of this clinical population.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Thioridazine, Butyrophenone, Haloperidol, Psychiatry, Schizophrenia (object-oriented programming), Population, Medicine, Psychosis